Corresponding Author: Nareg H. Roubinian, MD, Division of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA 94612 (nareg.n.roubinian@kp.org).

Author Contributions: Dr Roubinian and Ms Dusendang had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: All authors.

Acquisition, analysis, or interpretation of data: Roubinian, Dusendang, Mark, Vinson, Schmittdiel, Pai.

Drafting of the manuscript: Roubinian, Dusendang, Liu.

Critical revision of the manuscript for important intellectual content: Roubinian, Dusendang, Mark, Vinson, Schmittdiel, Pai.

Statistical analysis: Roubinian, Dusendang, Schmittdiel.

Obtained funding: Roubinian.

Administrative, technical, or material support: Liu, Schmittdiel, Pai.

Supervision: Roubinian, Schmittdiel.

Conflict of Interest Disclosures: Dr Roubinian reported grants from the National Institutes of Health and the National Heart, Lung, and Blood Institute (R01HL126130) during the conduct of the study. Dr Liu reported grants from the National Institute of General Medical Sciences (R35GM128672) during the conduct of the study. No other disclosures were reported.

Funding/Support: Funding for this work was provided by The Permanente Medical Group Delivery Science and Applied Research Program.

Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

References

Bilaloglu S , Aphinyanaphongs Y , Jones S , Iturrate E , Hochman J , Berger JS . Thrombosis in hospitalized patients with COVID-19 in a New York City health system. JAMA. 2020;324(8):799-801. doi:10.1001/jama.2020.13372 PubMed Google Scholar Crossref

Packard A , Delate T , Martinez K , Clark NP . Adherence to and persistence with direct oral anticoagulant therapy among patients with new onset venous thromboembolism receiving extended anticoagulant therapy and followed by a centralized anticoagulation service. Thromb Res. 2020;193:40-44. doi:10.1016/j.thromres.2020.05.036 PubMed Google Scholar Crossref

Spyropoulos AC , Ageno W , Albers GW , et al; MARINER Investigators. Rivaroxaban for thromboprophylaxis after hospitalization for medical illness. N Engl J Med. 2018;379(12):1118-1127. doi:10.1056/NEJMoa1805090 PubMed Google Scholar Crossref

Roberts LN , Whyte MB , Georgiou L , et al. Postdischarge venous thromboembolism following hospital admission with COVID-19. Blood. 2020;136(11):1347-1350. doi:10.1182/blood.2020008086 PubMed Google Scholar Crossref

Moores LK , Tritschler T , Brosnahan S , et al. Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report. Chest. 2020;158(3):1143-1163. doi:10.1016/j.chest.2020.05.559 PubMed Google Scholar Crossref

Gerotziafas GT , Catalano M , Colgan MP , et al; Scientific Reviewer Committee. Guidance for the management of patients with vascular disease or cardiovascular risk factors and COVID-19: position paper from VAS-European Independent Foundation in Angiology/Vascular Medicine. Thromb Haemost. 2020;120(12):1597-1628. doi:10.1055/s-0040-1715798 PubMed Google Scholar Crossref

Incidence of 30-Day Venous Thromboembolism in Adults Tested for SARS-CoV-2 Infection in an Integrated Health Care System in Northern California

See More About

If you are not a JN Learning subscriber, you can either:

A subscription to JN Learning (CME from JAMA Network) provides:

Sign in to access

If you are not a JN Learning subscriber, you can either:

Sign in to customize your interests

With a personal account, you can:

Name Your Search

Sign in to save your search

With a personal account, you can:

Lookup An Activity

My Saved Searches

Sign in to customize your interests

With a personal account, you can:

Purchase access